Key Takeaways Expanding product portfolio and investment in technology are enhancing market reach, salesforce productivity, and operational efficiency, supporting steadier long-term growth. Shifts toward at-home care and improved reimbursement are increasing demand, broadening patient access, and strengthening revenue stability beyond traditional core products.Read more
Catalysts About Tactile Systems Technology Tactile Systems Technology develops and commercializes medical devices that treat chronic lymphedema and airway clearance conditions, focusing on home-based, clinically validated therapies. What are the underlying business or industry changes driving this perspective?Read more
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
